psoriatic arthritis patient playing in water
woman playing baseball with her familywoman playing baseball with her family

For all the things that move you

Taltz is available to treat adult patients with active psoriatic arthritis (PsA) and is also used to treat adults and children 6 years and older with moderate to severe plaque psoriasis (PsO) who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet or UV light).

Select Safety Information

Taltz affects the immune system. It may increase your risk of infections, which can be serious. Do not use Taltz if you have any symptoms of infection, unless your doctor tells you to. If you have a symptom after starting Taltz, call your doctor right away.

Why your next move should be Taltz

JOINT SYMPTOM IMPROVEMENT FOR ADULTS WITH PSORIATIC ARTHRITIS

Taltz helped some patients experience improvement in PsA symptoms,* such as:

  • Joint pain and stiffness
  • Reduced mobility
  • Psoriasis skin plaques
  • Pain in tendons and ligaments where they are attached to bone (also known as enthesitis)
  • Swelling of fingers and toes (also known as dactylitis)

*Evaluated at 6 months.

Select Safety Information

Your doctor should check you for tuberculosis (TB) before you start Taltz, and watch you closely for signs of TB during and after treatment with Taltz. If you have TB, or had it in the past, your doctor may treat you for it before you start Taltz.

“Taltz has taken care of both my joints and skin.”

- Julie, actual Taltz patient with psoriatic arthritis. See her story.

Julie was compensated for her time.

WORKS QUICKLY

Some patients felt joint symptom relief in as early as 1 week.

Individual results may vary.


RELIEF THAT LASTS

Of all the patients taking Taltz who achieved joint symptom improvement at 6 months, more than half maintained those results at 3 years with continued treatment.

After completion of the initial clinical trial, additional data were collected in an extended, less rigorous study.


HELPS STOP PROGRESSION

For some people, Taltz is proven to help stop the progression of joint damage caused by psoriatic arthritis.§

§Measured at 4 months.


PERFORM DAILY ACTIVITIES

In clinical trials, almost half of patients with active psoriatic arthritis taking Taltz showed improvement in their ability to perform daily activities.||

||Measured at 6 months.


Select Safety Information

Do not use Taltz if you have had a serious allergic reaction to ixekizumab or any other ingredient in Taltz, such as: swelling of your eyelids, lips, mouth, tongue or throat, trouble breathing, feeling faint, throat or chest tightness, or skin rash. Get emergency help right away if you have any of these reactions. See the Medication Guide that comes with Taltz for a list of ingredients.

For patients with moderate to severe plaque psoriasis

100% CLEAR SKIN IS POSSIBLE

Up to 90% of people saw a significant improvement of their psoriasis plaques, with some even achieving 100% clear skin.

4 out of 10 achieved completely clear skin when measured at 3 months.

Select Safety Information

Taltz may cause or worsen symptoms of Crohn’s disease or ulcerative colitis (inflammatory bowel disease). Tell your doctor if you have any of these symptoms or if they get worse: stomach pain, diarrhea, and weight loss.

Taltz can help achieve clearer skin

Hear what people are saying.

TALTZ vs HUMIRA® (adalimumab)

For patients with active psoriatic arthritis

In a clinical trial, more Taltz patients than Humira patients achieved both of the following at the same time**:

  • Significant joint symptom improvement
  • 100% clear skin

**Measured at 6 months. All patients had plaque psoriasis, of which 17% was considered moderate to severe.
Humira® is a registered trademark of AbbVie Biotechnology Ltd.

“Taltz gives me very consistent relief. You're coached, as a rheumatology patient, to be prepared to wait several weeks for medicine to be effective, and I felt rapid relief with Taltz.”

- Julie, actual Taltz patient with psoriatic arthritis.

Julie was compensated for her time.

Select Safety Information

The most common side effects of Taltz include: injection site reactions, upper respiratory infections, nausea and fungal skin infections. Tell your doctor if you have any side effects. You can report side effects at 1-800-FDA-1088 or www.fda.gov/medwatch .

PURPOSE AND SAFETY SUMMARY

Important Facts About Taltz® (tȯl-ts). It is a prescription medicine also known as ixekizumab.

Taltz is an injectable medicine used to treat:

  • People 6 years of age and older with moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or treatment using ultraviolet or UV light (phototherapy).
  • Adults with active psoriatic arthritis.
  • Adults with active ankylosing spondylitis.
  • Adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation.

It is not known if Taltz is safe and effective in children for conditions other than plaque psoriasis or in children under 6 years of age.

WARNINGS

  • Taltz affects the immune system. It may increase your risk of infections, which can be serious. Do not use Taltz if you have any symptoms of infection, unless your doctor tells you to. If you have a symptom after starting Taltz, call your doctor right away.
  • Your doctor should check you for tuberculosis (TB) before you start Taltz, and watch you closely for signs of TB during and after treatment with Taltz.
  • If you have TB, or had it in the past, your doctor may treat you for it before you start Taltz.
  • Do not use Taltz if you have had a serious allergic reaction to ixekizumab or any other ingredient in Taltz, such as: swelling of your eyelids, lips, mouth, tongue or throat, trouble breathing, feeling faint, throat or chest tightness, or skin rash. Get emergency help right away if you have any of these reactions. See the Medication Guide that comes with Taltz for a list of ingredients.
  • Crohn’s disease or ulcerative colitis (inflammatory bowel disease) can start or get worse with Taltz use. Tell your doctor if you have any of these symptoms or if they get worse: stomach pain, diarrhea, and weight loss.
  • You should not get live vaccines while taking Taltz. You should get the vaccines you need before you start Taltz.

COMMON SIDE EFFECTS

The most common side effects of Taltz include:

  • Injection site reactions
  • Nausea
  • Upper respiratory infections
  • Fungal skin infections

Tell your doctor if you have any side effects. You can report side effects at 1-800-FDA-1088 or www.fda.gov/medwatch.

BEFORE USING

Before you use Taltz, review these questions with your doctor:

Are you being treated for an infection?
Do you have an infection that does not go away or keeps coming back?
Do you have TB or have you been in close contact with someone with TB?
Do you have possible symptoms of an infection such as fever, cough, sores, diarrhea, or other symptoms? Ask your doctor about other possible symptoms.
Do you have Crohn’s disease or ulcerative colitis?

Tell your doctor if:

You need any vaccines or have had one recently.
You take prescription or over-the-counter medicines, vitamins, or herbal supplements.
You are pregnant or planning to become pregnant. It is not known if Taltz can harm an unborn baby.
Pregnancy Registry: If you become pregnant while taking Taltz, you are encouraged to enroll in the pregnancy registry. The purpose of this registry is to collect information about the health of you and your baby. Talk to your healthcare provider or call 1-800-284-1695 to enroll in the registry.
You are breastfeeding or planning to breastfeed. It is not known if Taltz passes into breastmilk.

HOW TO TAKE

See the Instructions for Use that come with Taltz. There you will find information about how to store, prepare, and inject Taltz. Adults may self-inject after receiving training from a healthcare provider.

For people under 18 years of age:

  • Weighing less than 50 kg (i.e., 110 lb): Taltz must be given by a healthcare provider.
  • Weighing more than 50 kg (i.e., 110 lb): If your healthcare provider decides that your caregiver may give your injections of Taltz at home, your caregiver should ask and receive training from a healthcare provider on the right way to prepare and inject Taltz.

LEARN MORE

For more information, call 1-800-545-5979 or go to taltz.com .

This summary provides basic information about Taltz and is not comprehensive. Read the information that comes with your prescription each time your prescription is filled. This information does not take the place of talking with your doctor. Be sure to talk to your doctor or other healthcare provider about Taltz and how to take it. Your doctor is the best person to help you decide if Taltz is right for you.
Taltz® is a registered trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

IX CON BS 06JAN2022